Venable FDA and life sciences attorneys from offices around the country will be in San Francisco during the J.P. Morgan Healthcare Conference on January 8-11, 2024, participating in a number of related events in the city.
Clients rely on our decades of experience, keen knowledge of the marketplace, and unwavering commitment to outstanding service to address their most complex legal needs. Because the evolving legal and regulatory landscape is affecting our industry in unprecedented ways, Venable is pleased to provide you with an opportunity to sit down with one of our attorneys during the week in a one-on-one meeting* to discuss the legal issues facing your business.
To participate, submit a “Request a Meeting” below to ask questions about such issues as FDA and regulatory challenges, patent protection, intellectual property transactions, corporate financing, venture capital, mergers and acquisitions, and commercial contracts.
If you’d like to set up a meeting with us, please click above. We look forward to connecting with you!
*These consultations are not intended to create an attorney-client relationship. Any advice may be given only when it is related to specific fact situations that Venable has accepted an engagement as counsel to address.
CSSi LifeSciences Annual Partnering Forum at JPM Week 2024
Please join members of Venable’s FDA and Life Sciences groups at the 2024 CSSi LifeSciences Partnering Forum, as part of the 42nd Annual J.P. Morgan Healthcare Conference, in San Francisco on January 8-11, 2024, to discuss the latest developments impacting life sciences companies and drugs, biologics, and medical products manufacturers.
One of the nation’s leading law firms, Venable provides comprehensive legal services to fast-growing and emerging healthcare and life science companies. Members of our team have served as FDA officials and at other government agencies, which has provided them with deep knowledge of the regulatory paradigm and medical product development and approval process.
FDA Regulatory Considerations When Working with the Department of Defense
Wednesday, January 10 | 8:55 – 9:20 a.m. PT
Speaker
Jeremiah Kelly, MPP, RAC, Partner, Venable LLP
Mr. Kelly is the principal architect of the DoD's expedited approval mechanism, PL 115-92, and led the DoD’s legal response to COVID-19 through Operation Warp Speed. Come learn how research collaborations with the DoD can expedite medical product development through the complex FDA regulatory framework.
Venable-Hosted Reception, Hilton San Francisco Union Square
Tuesday, January 9 | 5:30 – 7:30 p.m. PT
Join us for an evening of drinks, hors d'oeuvres, and conversation. Our reception is conveniently located at the Hilton San Francisco Union Square, a 6-minute walk from the Westin St. Francis Hotel.
For more information, contact: Events@Venable.com
Meet Our Team
Jeremiah Kelly – Partner, FDA
Justin Coen – Partner, FDA
Chris Borello – Partner, IP Life Sciences Litigation
Bill Haddad – Partner, Life Sciences Corporate/Capital Markets
Jim Nelson – Partner, Life Sciences Corporate/Commercial Transactions
Alicia Russo – Partner, Life Sciences IP Transactions
Prajakta Sonalker, Ph.D. – Partner, IP Life Sciences Litigation